Experiment 928161
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | SC |
| Organism | Serratia marcescens (ENTEROBACTERIACEAE) |
| Citation | JAECKLE,KA: MITTELMAN,A: HILL,FH:. (1990). PHASE II TRIAL OF SERRATIA MARCESCENS EXTRACT IN RECURRENT MALIGNANT ASTROCYTOMA.. 8(8) |
| Amount utilized | |
| Compound isolated | |
| Disease | IN A PHASE II STUDY, 19 PATIENTS WITH RECURRENT ASTROCYTOMA WERE GIVEN A DOSE WEEKLY FOR 5 WEEKS. AFTER A 2 WEEK REST, A SECOND 5 WEEK COURSE AT THE SAME OR GREATER (3 MG/WK) DOSE WAS GIVEN. 2 PATIENTS SHOWED COMPLETE RESPONSE, 6 SHOWED MINOR RESPONSE AND THE REMAINDER, PROGRESSION. COMMON TOXICITIES WERE TRANSIENT TENDERNESS, INDURATION AND ERYTHEMA AT INJECTION SITES. SYSTEMIC EFFECTS WERE LESS FREQUENT: FEVER, CHILLS, NAUSEA/VOMITING, HEADACHE, ARTHRALGIA AND HYPOTENSION. |
| Dose amount | 1.0 MG |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | PERSON |
| Dose expression | DOSE |
| Extract | TYPE EXT NOT STATED |